Form SCHEDULE 13G/A Connect Biopharma Holdin Filed by: Wei Zheng

August 14, 2026 10:45 AM EDT





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
   Rule 13d-1(b)
   Rule 13d-1(c)
   Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person:  The percentage of beneficial ownership reported here is based on the total Ordinary Shares outstanding of 62,974,309 as disclosed in the Issuer's 10-Q reported for June 30, 2026.


SCHEDULE 13G



 
Wei Zheng
 
Signature:Zheng Wei
Name/Title:Individual
Date:08/14/2026


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings

Related Entities

13G